AIP
KNSA icon

Ameritas Investment Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Ameritas Investment Partners’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,649
Closed -$81K – 3272
2025
Q1 		$81K Hold
3,649
– – ﹤0.01% 1839
2024
Q4 		$72.2K Hold
3,649
– – ﹤0.01% 1972
2024
Q3 		$91.2K Buy
+3,649
New +$88.9K ﹤0.01% 1857
2024
Q2 		– Sell
-3,094
Closed -$61K – 3183
2024
Q1 		$61K Hold
3,094
– – ﹤0.01% 2034
2023
Q4 		$54.3K Hold
3,094
– – ﹤0.01% 2126
2023
Q3 		$53.7K Buy
3,094
+816
+36% +$13.7K ﹤0.01% 2059
2023
Q2 		$32.1K Hold
2,278
– – ﹤0.01% 2297
2023
Q1 		$24.5K Hold
2,278
– – ﹤0.01% 2386
2022
Q4 		$31.9K Hold
2,278
– – ﹤0.01% 2331
2022
Q3 		$29K Hold
2,278
– – ﹤0.01% 2323
2022
Q2 		$22K Hold
2,278
– – ﹤0.01% 2508
2022
Q1 		$23K Hold
2,278
– – ﹤0.01% 2495
2021
Q4 		$27K Hold
2,278
– – ﹤0.01% 2498
2021
Q3 		$26K Hold
2,278
– – ﹤0.01% 2559
2021
Q2 		$32K Hold
2,278
– – ﹤0.01% 2467
2021
Q1 		$42K Hold
2,278
– – ﹤0.01% 2187
2020
Q4 		$40K Hold
2,278
– – ﹤0.01% 2109
2020
Q3 		$35K Buy
2,278
+598
+36% +$11.2K ﹤0.01% 2052
2020
Q2 		$43K Buy
1,680
+705
+72% +$14.7K ﹤0.01% 1923
2020
Q1 		$15K Hold
975
– – ﹤0.01% 2335
2019
Q4 		$11K Hold
975
– – ﹤0.01% 2693
2019
Q3 		$8K Hold
975
– – ﹤0.01% 2810
2019
Q2 		$13K Buy
975
+440
+82% +$6.83K ﹤0.01% 2685
2019
Q1 		$10K Hold
535
– – ﹤0.01% 2695
2018
Q4 		$15K Hold
535
– – ﹤0.01% 2487
2018
Q3 		$14K Buy
+535
New +$10.4K ﹤0.01% 2689

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Ameritas Investment Partners's KNSA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2025, closing a stake of 3,649 shares — an estimated $81K sold.

Ameritas Investment Partners first reported a position in KNSA in Q3 2018 and held it in 26 quarters. The position peaked at $91.2K in Q3 2024. 189 funds tracked by Wall St. Rank hold KNSA as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Kiniksa Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,649 Kiniksa Pharmaceuticals shares in Q2 2025, an estimated $81K.
  • Ameritas Investment Partners first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and held it in 26 quarters.
  • Ameritas Investment Partners's Kiniksa Pharmaceuticals position peaked at $91.2K in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.